Published in Biotech Business Week, November 29th, 2004
Altana Pharma AG has signed a global licensing agreement to use of DecisionSite across the research organization from target discovery through clinical safety in four global locations. The company is currently using DecisionSite in functional genomics and lead discovery.
Altana selected Spotfire to help the organization in speeding up decision making processes by visualization and integration of research data. "Spotfire is helping us turn data into valuable information and bring it onto the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.